Novo-Nordisk A/S
Novo-Nordisk A/S price
About Novo-Nordisk A/S
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
- Stock ticker
- NVO
- Company
- Novo Nordisk A/S
- Industry
- Healthcare
- Category
- US
- Stock split / reverse split
- 12
- Launch date
- Apr 30, 1981
- Listed exchange
- NYSE
Financials
Summary: NVO reported Revenue of 11.90B (+3.25%), beating expectations; EPS of 0.89 (-12.75%), beating expectations.
Dividends
Novo-Nordisk A/S conversion tables
 |  |
|---|---|
| 0.5 NVO | 20.43 USD |
| 1 NVO | 40.87 USD |
| 5 NVO | 204.36 USD |
| 10 NVO | 408.72 USD |
| |
|---|---|
| 0.5 USD | 0.012233 NVO |
| 1 USD | 0.024467 NVO |
| 5 USD | 0.12233 NVO |
| 10 USD | 0.24467 NVO |
More to explore
FAQ
NVO is trading at $40.87, +0.55% over the last 24 hours. Track live moves on the price chart at the top of this page.
The NVO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. NVO is currently trading at $40.87, +0.55% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on NVO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. NVO's P/E ratio is currently 10.59 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from NVO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against NVO's historical range and other companies in the Healthcare sector.
Novo Nordisk A/S's market cap is currently 180.16B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.